Hodgkins Disease

12 registered clinical trials studyying Hodgkins Disease.

Status	Trial	Sponsor	Phase
Completed	Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplan NCT02639559	Washington University School of Medicine	Phase 2
Completed	Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention NCT01951885	Case Comprehensive Cancer Center	Phase 3
Terminated	Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell NCT01500161	Texas Oncology Cancer Center	Phase 2
Terminated	Breast-Sparing Proton Therapy for Hodgkin's Disease NCT02070393	Indiana University	EARLY_Phase 1
Completed	Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant NCT00901225	Duke University	Phase 2
Completed	Blood Samples to Evaluate Biomarkers of Donor Chimerism NCT00764829	Fred Hutchinson Cancer Center	—
Completed	A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Childre NCT00754286	Albert Einstein College of Medicine	N/A
Completed	Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI NCT00697684	Beth Israel Deaconess Medical Center	Phase 1
Completed	Health and Psychosocial Outcomes in Long-Term Lymphoma Survivors NCT00713882	Weill Medical College of Cornell University	—
Completed	Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Diseas NCT00364676	Spectrum Pharmaceuticals, Inc	Phase 1
Completed	Autologous and Allogeneic Transplant for Relapsed Lymphoma NCT00802113	Columbia University	Phase 1 / Phase 2
Completed	Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant NCT00571662	University of Nebraska	Phase 2